Pharmaceutical News

RSS

Old drug offers new hope for treatment of MND

An international study led by biochemists at the University of Liverpool has shown that the drug-molecule ebselen can correct many of the toxic characteristics of a protein that causes some cases of hereditary motor neurone disease (MND).

17 May 2018

Drug combination may prevent secondary stroke in certain patients, study shows

Results from an international clinical trial of more than 4880 participants, published in the New England Journal of Medicine, show that combining clopidogrel and aspirin following a small stroke or experiencing minor stroke symptoms decreases risk of a new stroke, heart attack or other ischemic event within 90 days.

17 May 2018

Doctors publish comprehensive proposal to ensure universal access to safe, affordable medications

The skyrocketing cost of prescription drugs is one of the biggest concerns for American voters. However, in his proposal last Friday, President Donald Trump failed to offer any new policies that would expand access, reduce costs, or increase the safety and efficacy of prescriptions.

17 May 2018

Expectant mothers may use RA drugs without increased health risks to unborn babies

A new study led by a team at the Research Institute of the MUHC in Montreal has revealed that pregnant women with rheumatoid arthritis may be able to use certain RA drugs without possible increased health risks to their unborn babies.

17 May 2018

FDA approves new treatment to mitigate opioid withdrawal symptoms in adults

The U.S. Food and Drug Administration today approved Lucemyra (lofexidine hydrochloride) for the mitigation of withdrawal symptoms to facilitate abrupt discontinuation of opioids in adults.

17 May 2018

Mayo Clinic researchers identify new possible treatment choice for triple negative breast cancer

In a recent study published in the Journal of Clinical Investigation, Mayo Clinic researchers identified that an FDA drug approved for myelodysplastic syndrome may be useful to treat triple-negative breast cancer, which is one of the most aggressive and lethal types of breast cancer.

16 May 2018

Clinical study shows promising results of Nexodyn AcidOxidizing Solution in healing chronic wounds

APR Applied Pharma Research sa, the Swiss independent developer of science driven and patent protected healthcare products, today announces the publication in "Advances in skin & wound care" of the results of a clinical pilot study on the efficacy and tolerability of Nexodyn AcidOxidizing Solution, a sprayable Active Cleanser with ancillary antimicrobial activity developed for acute and chronic wound management.

16 May 2018

Emulate partners with AstraZeneca to accelerate development of Organs-on-Chips technology

Emulate, Inc. has formed a collaborative partnership with AstraZeneca's Innovative Medicines and Early Development Biotech Unit to embed its Organs-on-Chips technology within the laboratories of the IMED Drug Safety organization.

16 May 2018

FDA clears Turnstone Biologics' IND for immunotherapy targeting HPV positive solid tumors

Turnstone Biologics today announced it has received U.S. Food and Drug Administration clearance of its Investigational New Drug Application for MG1-HPV for the treatment of patients with human papillomavirus positive solid tumors.

16 May 2018

Taking clot-preventing drug with aspirin may lower risk of major stroke, finds study

The research was part of the Platelet-Oriented Inhibition in New TIA and minor ischemic stroke trial -- a randomized, double-blind, placebo-controlled trial conducted between May 2010 and December 2017.

16 May 2018

Reversing an overdose isn’t complicated, but getting the antidote can be

A few months ago, Kourtnaye Sturgeon helped save someone’s life. She was driving in downtown Indianapolis when she saw people gathered around a car on the side of the road. Sturgeon pulled over, and a man told her there was nothing she could do: Two men had overdosed on opioids and appeared to be dead.

16 May 2018

MDMA appears to help in treating PTSD patients

When lasting trauma is caused by callous acts of violence, the key to recovery can be making meaning out of meaninglessness.

16 May 2018

First epoetin alfa biosimilar receives FDA approval to treat certain types of anemia

The U.S. Food and Drug Administration today approved Retacrit (epoetin alfa-epbx) as a biosimilar to Epogen/Procrit (epoetin alfa) for the treatment of anemia caused by chronic kidney disease, chemotherapy, or use of zidovudine in patients with HIV infection.

16 May 2018

Majority of prescription drug commercials focus on lifestyle improvements, study finds

Prescription drug commercials are getting longer and providing less factual information. A study published in the Annals of Family Medicine finds that the majority of these ads focus on lifestyle improvements made post-medication rather than side-effects and the negative emotions associated with certain health issues.

15 May 2018

Opioid pharmaceutical marketing influences physicians' opioid prescribing rates

A new study shows the significant impact that even a meal or two paid for by a pharmaceutical company can have on prescribing rates, despite a national decline of opioid prescribing rates.

15 May 2018

Acetaminophen use helps reduce acute kidney injury risk in pediatric heart surgery patients

Children who underwent cardiac surgery were less likely to develop acute kidney injury if they had been treated with acetaminophen in the first 48 hours after their procedures, according to a Vanderbilt study just published in JAMA Pediatrics.

15 May 2018

European regulatory approves BMG Pharma’s GelX for prevention of oral mucositis

BMG Pharma S.r.l., an innovative specialty pharmaceutical company, is pleased to announce the European regulatory approval for its GelX product to be used for the prevention of oral mucositis.

14 May 2018

Study: Effective intervention can reduce medication overuse in aged care facilities

Effective intervention can reduce medication overuse in Residential Aged Care Facilities, the latest University of Tasmania research shows.

14 May 2018

FDA approves new drug to treat MS in pediatric patients

The U.S. Food and Drug Administration today approved Gilenya (fingolimod) to treat relapsing multiple sclerosis (MS) in children and adolescents age 10 years and older. This is the first FDA approval of a drug to treat MS in pediatric patients.

14 May 2018

Trump vows (again) to lower drug prices but skeptics doubt much will change

President Donald Trump, armed with the expertise of staff seasoned in the ways of the drug industry, unveiled his blueprint to address sky-high drug prices Friday afternoon, promising that increasing industry competition will help Americans save at the pharmacy counter.

11 May 2018

Pharmaceutical News

Old drug offers new hope for treatment of MND

Drug combination may prevent secondary stroke in certain patients, study shows

Doctors publish comprehensive proposal to ensure universal access to safe, affordable medications

Expectant mothers may use RA drugs without increased health risks to unborn babies

FDA approves new treatment to mitigate opioid withdrawal symptoms in adults

Mayo Clinic researchers identify new possible treatment choice for triple negative breast cancer

Clinical study shows promising results of Nexodyn AcidOxidizing Solution in healing chronic wounds

Emulate partners with AstraZeneca to accelerate development of Organs-on-Chips technology

FDA clears Turnstone Biologics' IND for immunotherapy targeting HPV positive solid tumors

Taking clot-preventing drug with aspirin may lower risk of major stroke, finds study

Reversing an overdose isn’t complicated, but getting the antidote can be

MDMA appears to help in treating PTSD patients

First epoetin alfa biosimilar receives FDA approval to treat certain types of anemia

Majority of prescription drug commercials focus on lifestyle improvements, study finds

Opioid pharmaceutical marketing influences physicians' opioid prescribing rates

Acetaminophen use helps reduce acute kidney injury risk in pediatric heart surgery patients

European regulatory approves BMG Pharma’s GelX for prevention of oral mucositis

Study: Effective intervention can reduce medication overuse in aged care facilities

FDA approves new drug to treat MS in pediatric patients

Trump vows (again) to lower drug prices but skeptics doubt much will change

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News